Ligand · 0CI
0CI · 5-(1-{[(3S)-1-propanoylpyrrolidin-3-yl]oxy}isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one
0CI, 5-(1-{[(3S)-1-propanoylpyrrolidin-3-yl]oxy}isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one (C18 H19 N5 O3, 353.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- 0CI
- Formula
- C18 H19 N5 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0CI in 2 structures; the first of them:
- 7N5Y · Fragment-Based Drug Design of a Novel, Covalent Bruton's Tyrosine Kinase Inhibitor · 0CI A702 · binds LEU408, GLY409, THR410, GLY411, VAL416, ALA428, LYS430, VAL458 and 9 more
- 7N5Y · Fragment-based drug design of a novel, covalent BRUTON'S tyrosine kinase inhibitor · 0CI A702 · binds LEU408, GLY409, THR410, VAL416, ALA428, LYS430, THR474, GLU475 and 7 more
Residues it binds most
GLY 2, ALA 2, LEU 2, THR 2, VAL 2, ARG 2, CYS 2, GLU 2, LYS 2, MET 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.